[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti-Obesity Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 201 pages | ID: GC325165453EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Anti-Obesity Devices Market:

Global anti-obesity devices market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for anti-obesity devices is projected to reach US$ XX Mn by 2023.

Obesity is a medical condition that can be defined as abnormal or excessive fat accumulation, which may have the negative effect on health. According to World Health Organisation, a person with BMI of 30 or more is generally considered as obese. Obesity increases the chances of diseases like chronic diseases, including diabetes, cardiovascular diseases, osteoarthritis, and certain types of cancers. Obesity mainly caused by excessive food intake, lack of physical, exercise, genetic inheritance, and rarely it occurs due to endocrine disorders, medications, and mental disorders. U.S. Food and Drug Administration approved the anti-obesity devices for the treatment of obesity. Obesity can be overcome by changing the diet conditions, and physical activities.

The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.

Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user

Based on product-type, anti-obesity devices market has been segmented into the following:
  • Gastric bands
  • Electrical stimulation system
  • Gastric balloon system
  • Gastric emptying system
  • Appetite suppressors
Based on the method of deployment, anti-obesity devices market has been segmented into the following:
  • Trans-oral
  • Endoscopy
  • Surgery
Based on the end user, anti-obesity devices market has been segmented into the following:
  • Hospitals
  • Gastroenterology clinics
  • Ambulatory surgical centers
Global anti-obesity devices market is in the nascent stage with local, and international players operating in the anti-obesity devices market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of anti-obesity devices market positively. For instance, In January 2015, FDA has approved the EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period.

Geographically, the anti-obesity devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North American region is witnessed significant growth owing to the rise in a number of obese patients, according to American Heart Association, 70% American adults are obese or overweight. Moreover, according to the WHO in the European region, in 2012, about 50% of adults are suffering from obesity, which plays a key role in the global anti-obesity devices market growth. The Asia Pacific region is a key market for global anti-obesity devices due to the increase in obese patients, improving healthcare expenditure, and higher investments in healthcare which is expected to fuel the market for anti-obesity devices in Asia Pacific region.

Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few

In January 2017, GI Dynamics Inc.’s EndoBarrier receives German NUB reimbursement status 1 for type 2 diabetes and obesity therapy

REPORT OUTLINE:
  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY

2. GLOBAL ANTI-OBESITY DEVICES MARKET INTRODUCTION

2.1. Global Anti-Obesity Devices Market– Taxonomy
2.2. Global Anti-Obesity Devices Market–Definitions
  2.2.1. Product Type
  2.2.2. End User

3. GLOBAL ANTI-OBESITY DEVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anti-Obesity Devices Market Dynamics – Factors Impact Analysis
3.6. Global Anti-Obesity Devices Market– Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan
3.7. Global Anti-Obesity Devices Market– Recent Product Launches

4. GLOBAL ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL ANTI-OBESITY DEVICES MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Gastric Bands
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Electrical Stimulation System
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Gastric Balloon System
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Gastric Emptying System
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Appetite Suppressors
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis

6. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY METHOD OF DEPLOYMENT, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Trans-oral
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Endoscopy
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Surgery
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Gastroenterology Clinics
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centers
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Region, 2017 – 2023

9. NORTH AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    9.1.1.1. Gastric Bands
    9.1.1.2. Electrical Stimulation System
    9.1.1.3. Gastric Balloon System
    9.1.1.4. Gastric Emptying System
    9.1.1.5. Appetite Suppressors
  9.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Trans-oral
    9.1.2.2. Endoscopy
    9.1.2.3. Surgery
  9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Hospitals
    9.1.3.2. Gastroenterology clinics
    9.1.3.3. Ambulatory surgical centers
  9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    9.1.4.1. U.S.
    9.1.4.2. Canada
  9.1.5. North America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
  9.1.6. North America Anti-Obesity Devices Market Dynamics – Trends

10. EUROPE ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Gastric Bands
    10.1.1.2. Electrical Stimulation System
    10.1.1.3. Gastric Balloon System
    10.1.1.4. Gastric Emptying System
    10.1.1.5. Appetite Suppressors
  10.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Trans-oral
    10.1.2.2. Endoscopy
    10.1.2.3. Surgery
  10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Hospitals
    10.1.3.2. Gastroenterology clinics
    10.1.3.3. Ambulatory surgical centers
  10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Germany
    10.1.4.2. UK
    10.1.4.3. France
    10.1.4.4. Spain
    10.1.4.5. Italy
    10.1.4.6. Russia
    10.1.4.7. Poland
    10.1.4.8. Rest of Europe
  10.1.5. Europe Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
  10.1.6. Europe Anti-Obesity Devices Market Dynamics – Trends

11. ASIA-PACIFIC ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Gastric Bands
    11.1.1.2. Electrical Stimulation System
    11.1.1.3. Gastric Balloon System
    11.1.1.4. Gastric Emptying System
    11.1.1.5. Appetite Suppressors
  11.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Trans-oral
    11.1.2.2. Endoscopy
    11.1.2.3. Surgery
  11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Hospitals
    11.1.3.2. Gastroenterology clinics
    11.1.3.3. Ambulatory surgical centers
  11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    11.1.4.1. Japan
    11.1.4.2. China
    11.1.4.3. India
    11.1.4.4. ASEAN
    11.1.4.5. Australia & New Zealand
    11.1.4.6. Rest of Asia-Pacific
  11.1.5. Asia-Pacific Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
  11.1.6. Asia-Pacific Anti-Obesity Devices Market Dynamics – Trends

12. LATIN AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Gastric Bands
    12.1.1.2. Electrical Stimulation System
    12.1.1.3. Gastric Balloon System
    12.1.1.4. Gastric Emptying System
    12.1.1.5. Appetite Suppressors
  12.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Trans-oral
    12.1.2.2. Endoscopy
    12.1.2.3. Surgery
  12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Hospitals
    12.1.3.2. Gastroenterology clinics
    12.1.3.3. Ambulatory surgical centers
  12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Brazil
    12.1.4.2. Mexico
    12.1.4.3. Argentina
    12.1.4.4. Venezuela
    12.1.4.5. Rest of Latin America
  12.1.5. Latin America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
  12.1.6. Latin America Anti-Obesity Devices Market Dynamics – Trends

13. MIDDLE EAST & AFRICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Gastric Bands
    13.1.1.2. Electrical Stimulation System
    13.1.1.3. Gastric Balloon System
    13.1.1.4. Gastric Emptying System
    13.1.1.5. Appetite Suppressors
  13.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Trans-oral
    13.1.2.2. Endoscopy
    13.1.2.3. Surgery
  13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Hospitals
    13.1.3.2. Gastroenterology clinics
    13.1.3.3. Ambulatory surgical centers
  13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.4.1. Gulf Cooperation Council (GCC) Countries
    13.1.4.2. Israel
    13.1.4.3. South Africa
    13.1.4.4. Rest of MEA
  13.1.5. MEA Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
  13.1.6. MEA Anti-Obesity Devices Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Allergan, Inc. (U.S.)
  14.2.2. Medtronic. (Covidien PLC) (U.S.)
  14.2.3. EnteroMedics, Inc (U.S.)
  14.2.4. Cousin Biotech (France)
  14.2.5. Surgical IOC (Peters Surgical SAS) (France)
  14.2.6. PARE Surgical Inc. (U.S.)
  14.2.7. GI Dynamics (U.S.)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications